rs17875327
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_004969.4(IDE):c.662-10T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0917 in 1,568,604 control chromosomes in the GnomAD database, including 7,869 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.072 ( 566 hom., cov: 32)
Exomes 𝑓: 0.094 ( 7303 hom. )
Consequence
IDE
NM_004969.4 intron
NM_004969.4 intron
Scores
2
Splicing: ADA: 0.3518
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 1.22
Publications
14 publications found
Genes affected
IDE (HGNC:5381): (insulin degrading enzyme) This gene encodes a zinc metallopeptidase that degrades intracellular insulin, and thereby terminates insulins activity, as well as participating in intercellular peptide signalling by degrading diverse peptides such as glucagon, amylin, bradykinin, and kallidin. The preferential affinity of this enzyme for insulin results in insulin-mediated inhibition of the degradation of other peptides such as beta-amyloid. Deficiencies in this protein's function are associated with Alzheimer's disease and type 2 diabetes mellitus but mutations in this gene have not been shown to be causitive for these diseases. This protein localizes primarily to the cytoplasm but in some cell types localizes to the extracellular space, cell membrane, peroxisome, and mitochondrion. Alternative splicing results in multiple transcript variants encoding distinct isoforms. Additional transcript variants have been described but have not been experimentally verified.[provided by RefSeq, Sep 2009]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.54).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.103 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0719 AC: 10928AN: 152056Hom.: 566 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
10928
AN:
152056
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0805 AC: 18109AN: 224962 AF XY: 0.0815 show subpopulations
GnomAD2 exomes
AF:
AC:
18109
AN:
224962
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0938 AC: 132923AN: 1416428Hom.: 7303 Cov.: 28 AF XY: 0.0926 AC XY: 65002AN XY: 702312 show subpopulations
GnomAD4 exome
AF:
AC:
132923
AN:
1416428
Hom.:
Cov.:
28
AF XY:
AC XY:
65002
AN XY:
702312
show subpopulations
African (AFR)
AF:
AC:
403
AN:
31600
American (AMR)
AF:
AC:
1402
AN:
36018
Ashkenazi Jewish (ASJ)
AF:
AC:
1789
AN:
24336
East Asian (EAS)
AF:
AC:
6
AN:
39144
South Asian (SAS)
AF:
AC:
2369
AN:
78198
European-Finnish (FIN)
AF:
AC:
8390
AN:
52648
Middle Eastern (MID)
AF:
AC:
130
AN:
5572
European-Non Finnish (NFE)
AF:
AC:
113910
AN:
1090444
Other (OTH)
AF:
AC:
4524
AN:
58468
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.468
Heterozygous variant carriers
0
4845
9690
14534
19379
24224
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
4040
8080
12120
16160
20200
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0718 AC: 10920AN: 152176Hom.: 566 Cov.: 32 AF XY: 0.0721 AC XY: 5363AN XY: 74378 show subpopulations
GnomAD4 genome
AF:
AC:
10920
AN:
152176
Hom.:
Cov.:
32
AF XY:
AC XY:
5363
AN XY:
74378
show subpopulations
African (AFR)
AF:
AC:
653
AN:
41542
American (AMR)
AF:
AC:
789
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
AC:
240
AN:
3472
East Asian (EAS)
AF:
AC:
8
AN:
5184
South Asian (SAS)
AF:
AC:
150
AN:
4812
European-Finnish (FIN)
AF:
AC:
1750
AN:
10560
Middle Eastern (MID)
AF:
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
AC:
7134
AN:
68000
Other (OTH)
AF:
AC:
127
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
493
986
1478
1971
2464
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
132
264
396
528
660
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
62
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
dbscSNV1_RF
Benign
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.